KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Repurchased
Ratios

Gilead Sciences (GILD) Leases (2019 - 2025)

Gilead Sciences (GILD) has disclosed Leases for 10 consecutive years, with $532.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases rose 3.3% year-over-year to $532.0 million, compared with a TTM value of $532.0 million through Dec 2025, up 3.3%, and an annual FY2025 reading of $532.0 million, up 3.3% over the prior year.
  • Leases was $532.0 million for Q4 2025 at Gilead Sciences, up from $515.0 million in the prior quarter.
  • Across five years, Leases topped out at $581.0 million in Q4 2023 and bottomed at $505.0 million in Q4 2022.
  • Average Leases over 5 years is $535.0 million, with a median of $532.0 million recorded in 2025.
  • The sharpest move saw Leases decreased 16.1% in 2021, then rose 15.05% in 2023.
  • Year by year, Leases stood at $542.0 million in 2021, then fell by 6.83% to $505.0 million in 2022, then increased by 15.05% to $581.0 million in 2023, then dropped by 11.36% to $515.0 million in 2024, then rose by 3.3% to $532.0 million in 2025.
  • Business Quant data shows Leases for GILD at $532.0 million in Q4 2025, $515.0 million in Q4 2024, and $581.0 million in Q4 2023.